BioScience Health Innovations, Inc. Cash Flow Statement
BHIC|6 years of annual SEC 10-K data (FY2020-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 6 fiscal years. All figures from audited SEC 10-K filings.
BioScience Health Innovations, Inc. generated $172,178 in operating cash flow in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 7.48 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income | $642.1K | $87.0K | -$251.5K | -$170.4K | -$25.6K | -$7.7K |
| Operating Cash Flow | $172.2K | $23.2K | -$307.8K | -$182.8K | -$29.4K | -$7.7K |